MitoQ for Fatigue in Multiple Sclerosis (MS)

NCT04267926 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

FED

Sponsor class

Conditions

Multiple Sclerosis
Fatigue

Interventions

DRUG: 20 mg MitoQ
DRUG: Placebo
DRUG: 40mg of MitoQ

Sponsor

VA Office of Research and Development